Clinical Trials Browser

Interventional × Has results × GDC-0084 × Clear all

NCT03765983 2026-05-27

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

17 enrolled 14 charts

Breast Neoplasms

NCT03522298 2025-03-24

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Phase 2 Completed

30 enrolled 27 charts

Glioblastoma